A weekly in depth discussion of two pre-selected relevant recent publications from the biomedical literature
Monday, May 20th 2013 (2:00-3:30pm) Location: 3535 Market Street 16th Floor Conference Room D Guest Speaker: Dr. David Chambers Associate Director, Dissemination and Implementation Research, NIMH
Research Areas: Dissemination and implementation of mental health care interventions
Professor Cell and Developmental Biology
"Hematopoietic stem cell formation in the embryo".
Class of '62
Professor of Immunology
Humoral responses to HIV-1 neutralizing epitopes
*Co-Sponsored by CFAR
Austrian Auditorium, CRB
209 Johnson Pavilion: Kaycie Hopkins, Cherry Lab
Department of Radiation OncologyJournal ClubSTCR 8-146AB
Andrea Facciabene, Ph.D.
Research Assistant Professor of Obstetrics and Gynecology
Ovarian Cancer Research Center
Perelman School of Medicine
University of Pennsylvania
Mitochondria an eukaryotic commensal as new source of Tumor Associated Antigen
Rodebaugh Diabetes Center Conference Series Presents:
Topic: DM and Bariatric Surgery
CRB Austrian Auditorium
"Hematopoietic stem cell formation in the embryo"
JMB Class of '62
Department of Radiation OncologyFaculty Meeting2-3PM (changed from 5/17 1pm)PCAM Board Room
Recent approaches to drug discoveries focus upon the better understanding of the biochemical pathways that govern the pathogenesis of diseases at a molecular level. Previous studies have shown that malignant cells of many cancers expressed on their surface in high density, a genomic product VPAC1 combined for vasoactive intestinal and pituitary adenylate cyclase activating peptide. These finger prints, the receptors, encode G protein, involved in cell proliferation, differentiation and cell survival. On benign or normal cells, only a few VPAC1 receptors are present. We therefore hypothesized that targeting VPAC1 using a specific biomolecule labeled with a positron emitting radionuclide will permit us not only to image early cancers of the breast (BC), prostate (PC) and lung (LC), but will also distinguish benign lesions from malignant masses. Early data shall be presented.
After completing this activity, participants should be able to:
• Apply the latest clinical guidelines in the management of endocrine diseases • Evaluate and efficacy of therapeutic options in endocrine disorders • Describe the results of translational research as it pertains to endocrine diseases
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Tom Bebee - Carstens Lab
"A conditional knockout mouse model to define the roles of the Epithelial Splicing Regulatory Proteins 1 and 2 (Esrp1 and Esrp2) in development and epithelial cell function"